-The Hindu The Centre will soon implement Phase II of the Rajiv Awas Yojna with a focus on providing long-term and bankable property rights to slum dwellers, Union Housing and Urban Poverty Alleviation Minister Ajay Maken said, soon after taking charge of his new Ministry on Tuesday. Talking to journalists at his office in Nirman Bhavan, Mr. Maken said the Centre will adopt the twin strategy of funding and “mandatory reforms” in...

-Pratirodh.com The fanfare with which Prime Minister Manmohan Singh and Congress president Sonia Gandhi launched a service delivery scheme in Rajasthan based on the Aadhaar (foundation) unique identity (UID), and celebrated the issue of the first Aadhaar number topping the 200-million mark, should make the Indian National Congress a very worried party indeed—assuming it has a good survival instinct and basic grasp of practical politics.    To put it starkly, the Congress and...

-The Indian Express MHA’s decision to replicate the Chhattisgarh model in all Maoist-affected states is timely Taking a cue from the Chhattisgarh police’s efforts to socially rehabilitate Maoists cadres who have surrendered, the ministry of home affairs (MHA) has issued an advisory saying that all Naxal-affected states should facilitate reverse vasectomy operations for Maoists who wish to join the mainstream. The states should bear the medical costs for the operation, which will...

-The Times of India Delhi, which was not even among the world's top ten urban sprawls by population in 1990, is already the second largest behind Tokyo and will continue to retain that position till 2025, according to a UN projection. Mumbai, which was at No. 5 in 1990, has climbed to the fourth spot and will be No. 3 in the next 13 years. The projections made in the UN's recent...

-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...